Cargando…

The combination astemizole–gefitinib as a potential therapy for human lung cancer

Lung cancer is a major cause of cancer mortality. Thus, novel therapies are urgently needed. Repositioning of old drugs is gaining great interest in cancer treatment. Astemizole is an antihistamine proposed to be repositioned for cancer therapy. This drug targets several molecules involved in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chávez-López, María de Guadalupe, Zúñiga-García, Violeta, Hernández-Gallegos, Elisabeth, Vera, Eunice, Chasiquiza-Anchatuña, Carmen Alexandra, Viteri-Yánez, Marco, Sanchez-Ramos, Janet, Garrido, Efraín, Camacho, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724417/ https://www.ncbi.nlm.nih.gov/pubmed/29263676 http://dx.doi.org/10.2147/OTT.S144506

Ejemplares similares

Eag1 Gene and Protein Expression in Human Retinoblastoma Tumors and Its Regulation by pRb in HeLa Cells
por: Chávez-López, María de Guadalupe, et al.
Publicado: (2020)

The effects of topical (gel) astemizole and terfenadine on wound healing
por: Srikanth, D., et al.
Publicado: (2008)

Mechanism of Block of hEag1 K(+) Channels by Imipramine and Astemizole
por: García-Ferreiro, Rafael E., et al.
Publicado: (2004)

Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking
por: Lyu, Junfang, et al.
Publicado: (2018)

Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro
por: Wang, Xiangjun, et al.
Publicado: (2021)

Astemizole Sensitizes Adrenocortical Carcinoma Cells to Doxorubicin by Inhibiting Patched Drug Efflux Activity
por: Hasanovic, Anida, et al.
Publicado: (2020)

Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
por: Zhang, Shuai, et al.
Publicado: (2023)

El astemizol en el tratamiento de los transtornos vasomotores del síndrome climatérico.
por: Jácome Martínez, Julio Sócrates
Publicado: (1995)

Astemizole Synergizes Calcitriol Antiproliferative Activity by Inhibiting CYP24A1 and Upregulating VDR: A Novel Approach for Breast Cancer Therapy
por: García-Quiroz, Janice, et al.
Publicado: (2012)

Assessment of General and Cardiac Toxicities of Astemizole in Male Cynomolgus Monkeys: Serum Biochemistry and Action Potential Duration
por: Lee, Jong-Hwa, et al.
Publicado: (2008)

In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors
por: García-Quiroz, Janice, et al.
Publicado: (2014)

The hEag1 K(+) Channel Inhibitor Astemizole Stimulates Ca(2+) Deposition in SaOS-2 and MG-63 Osteosarcoma Cultures
por: Mészáros, Beáta, et al.
Publicado: (2022)

Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
por: Chávez-López, María de Guadalupe, et al.
Publicado: (2016)

Expression of K(ATP) channels in human cervical cancer: Potential tools for diagnosis and therapy
por: Vázquez-Sánchez, Alma Yolanda, et al.
Publicado: (2018)

El programa para el desarrollo integral del adolescente
por: Chavez Viteri, Javier Fernando
Publicado: (1997)

Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
por: Pan, Chi, et al.
Publicado: (2020)

Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
por: Tang, Mei-Chuan, et al.
Publicado: (2015)

Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib‐effective patients with advanced NSCLC
por: Qin, Yijia, et al.
Publicado: (2016)

Rhabdomyolysis Caused by Gefitinib Overdose
por: Obayashi, Shohei, et al.
Publicado: (2021)

Gefitinib: Dermatitis: case report
Publicado: (2022)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2007)

Combined treatment with N‐acetylcysteine and gefitinib overcomes drug resistance to gefitinib in NSCLC cell line
por: Li, Jun, et al.
Publicado: (2019)

Differential regulation of human Eag1 channel expression by serum and epidermal growth factor in lung and breast cancer cells
por: Acuña-Macías, Isabel, et al.
Publicado: (2015)

ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC
por: Zhao, Hongbo, et al.
Publicado: (2018)

Predicting Tumor Responses to Gefitinib and Erlotinib
Publicado: (2005)

Alitretinoin Treatment for Gefitinib-Induced Paronychia
por: Lee, Soo Young, et al.
Publicado: (2019)

Phase I study of irinotecan and gefitinib in patients with gefitinib treatment failure for non-small cell lung cancer
por: Horiike, A, et al.
Publicado: (2011)

Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib
por: Nagano, Tatsuya, et al.
Publicado: (2011)

Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
por: Yuan, Ying, et al.
Publicado: (2012)

Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer
por: Zou, Zheng-Zhi, et al.
Publicado: (2015)

The cytotoxicity of gefitinib on patient‑derived induced pluripotent stem cells reflects gefitinib‑induced liver injury in the clinical setting
por: Fujisaka, Yasuhito, et al.
Publicado: (2023)

Gefitinib in Non Small Cell Lung Cancer
por: Costanzo, Raffaele, et al.
Publicado: (2011)

Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
Publicado: (2012)

Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
por: Stoppoloni, Daniela, et al.
Publicado: (2010)

Acquired Gefitinib-Resistant Mutation of EGFR in a Chemonaive Lung Adenocarcinoma Harboring Gefitinib-Sensitive Mutation L858R
por: Gow, Chien-Hung, et al.
Publicado: (2005)

Efficacy of chemotherapy plus gefitinib treatment in advanced non-small-cell lung cancer patients following acquired resistance to gefitinib
por: SONG, ZHENGBO, et al.
Publicado: (2013)

Gefitinib upregulates death receptor 5 expression to mediate rmhTRAIL-induced apoptosis in Gefitinib-sensitive NSCLC cell line
por: Yan, Dong, et al.
Publicado: (2015)

Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis
por: Yi, Min, et al.
Publicado: (2023)

HPV16-E2 protein modifies self-renewal and differentiation rate in progenitor cells of human immortalized keratinocytes
por: Domínguez-Catzín, Victoria, et al.
Publicado: (2017)

Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9/G NSCLC cells
por: Zhu, Yinsong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b2ujafvkn6b01j82dk6rdulnes